Axon Enterprise stock has delivered a very strong 191.8% return over the past three years, yet its valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value suggesting the shares trade at a premium while market multiples lean the other way.

• Axon Enterprise is up 191.8% over three years, which puts extra focus on whether recent gains are supported by underlying value.
• RBC Capital Markets expects bookings growth helped by new products and international expansion, while execution risks around scaling a broader connected platform and counter drone offering may affect how confidently investors underwrite that growth.
• With a low value score of 2 out of 6 checks, Axon Enterprise does not screen as a clear bargain on the broader valuation tests, even though some multiples screen as undervalued.

The issue now is whether the current Axon Enterprise share price already factors in the growth story, or if the gap between the intrinsic value estimate and the multiples still leaves room for long term buyers.

Does Axon Enterprise Look Pricey on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what Axon Enterprise might be worth based on projected future cash generation. On this approach, Axon’s latest twelve month free cash flow sits at about $28.7 million, and the model assumes that cash flows grow from this base over the coming years.

Those projections lead to an estimated intrinsic value of about $431 per share. Compared with the current share price, the DCF implies the stock trades roughly 22.6% above that estimate, so Axon Enterprise screens as overvalued on this method. RBC Capital Markets has highlighted potential bookings growth from new products and international expansion, which helps explain why the market is already assigning a rich price to that future cash flow story.

On this cash flow view, Axon Enterprise stock currently looks overvalued relative to its estimated intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 22.6%. Discover 55 high quality undervalued stocks or create your own screener to find better value opportunities.

Is Axon Enterprise a Bargain on Sales?

P/S is a useful lens for Axon Enterprise because investors often focus on how much they are paying for each dollar of revenue in fast growing, subscription heavy business models. Axon Enterprise currently trades at a P/S ratio of 14.3x, which is well above the Aerospace & Defense industry average of 4.8x, yet below the peer average of 20.4x.

The fair P/S ratio for Axon Enterprise, based on factors such as its growth profile, margins, scale and risk, is estimated at 16.8x. That is higher than the current 14.3x level, which suggests the stock screens as undervalued on this metric even though it already carries a premium to the broader industry.

On the P/S multiple alone, Axon Enterprise appears undervalued relative to the level implied by its fundamentals and peer group.

The Axon Enterprise Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Axon Enterprise aim to connect this valuation puzzle to concrete assumptions about Axon Enterprise's future growth, margins and earnings that would need to hold for the stock to be worth materially more or less than today's price. They sit on the company’s Community page. Each one ties a specific fair value to a clear story about Axon Enterprise's potential catalysts and risks so you can assess over time which version of events appears to be playing out.

Community views on Axon Enterprise sit far apart, with one camp seeing long runway left and the other focused on how much is already priced in.

Bull case: 20% undervalued

"Fast-track adoption of new Axon products such as Draft One (AI), TASER 10, Axon Body 4, and Dedrone (counter-drone) is driving up average deal values and product bundles per customer..."

Bear case: 29% overvalued

"The rapid commoditization of AI-driven cameras, cloud storage, and real-time analytics threatens to erode Axon's hardware and software competitive advantage, increasing pricing pressure and potentially compressing gross margins as cheaper alternatives become widely available..."

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

The Bottom Line

Axon Enterprise now sits in a grey zone where the Discounted Cash Flow (DCF) intrinsic value points to an overvalued stock, while the sales multiple suggests some undervaluation relative to peers. That split largely reflects different weight on cash flow timing and capital needs versus expectations for growth and sentiment around high revenue multiples. The broader checks still look weak, so the supportive P/S signal does not remove the risk that optimism is already embedded. The key question from here is whether Axon can deliver the growth and execution on its broader connected platform that would make today’s valuation look reasonable over time.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.